side effects of tirzepatide and semaglutide health risks Effects: Short-Term vs. Long-Term Impacts on Your vs. Semaglutide: What You Tirzepatide vs Semaglutide: Which Weight

Foundation for Clinically Proven Weight Loss: When followed through to the 2.4 mg maintenance dose, Wegovy produced a mean weight loss of up to 15.6% in the STEP UP trial, with the 1.7 mg dose playing a critical role in the gradual dose escalation that minimizes gastrointestinal side effects

Neuroprotective & Mitochondrial Studies GH and IGF-1 have demonstrated neuroprotective and mitochondrial support roles , suggesting potential utility for investigating neurodegenerative and aging-related processes [Frohman 2000]

The FDA has flagged safety risks for several compounded peptides, including immunogenicity and impurity concerns

Decline in skeletal muscle mitochondrial function with aging in humans

Because the fat pads that support the mid-face and lower face diminish so rapidly, gravity begins to take a visible toll